Delivery Order SPE2DB20D2104-SPE2DB25FNAVM
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,554.64 by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Premarin 0.3 mg tablets (100-count units). The contract carries a firm fixed price structure with no set-aside designation and an ultimate completion date of July 31, 2025. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on May 1, 2025, for Premarin 0.3 mg tablets (100-count supply) with a ceiling value of $9,080.38. This firm fixed-price, non-set-aside contract reflects the completion of a single delivery under AmerisourceBergen's broader relationship with DLA, with an ultimate completion date of May 2, 2025. The award represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $4,119.57 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Premarin 0.3 mg on July 14, 2025, with completion expected by July 15, 2025. This is a firm fixed-price contract with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Premarin 0.3 mg tablets in quantities of 100 units at a ceiling value of $3,306.05. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $11,614.48 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price contract involves no set-aside designation and represents a competitive award to the major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,719.90 to AmerisourceBergen Drug Corp for the supply of Premarin 0.3 mg tablets (100-count units) on September 3, 2025, with an ultimate completion date of September 4, 2025. The contract utilizes firm fixed price pricing and is not designated as a set-aside. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this delivery order, which falls under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.3 mg with a ceiling value of $1,052.49. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of September 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $8,600.44 to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.625 mg on July 25, 2025, with an ultimate completion date of July 28, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this award is issued under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Premarin 0.3 mg tablets (100 count) on August 14, 2025, with an ultimate completion date of August 15, 2025. Valued at $1,512.09 under a firm fixed-price arrangement, this non-competitive delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. The contract is fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on July 25, 2025, to supply 1,000 tablets of Premarin 0.625 mg at a fixed price of $3,251.40, with completion scheduled for July 28, 2025. This non-set-aside, competitively awarded contract represents a routine pharmaceutical procurement supporting federal medical supply needs. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNAVMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.3 mg with a ceiling value of $4,054.67. This is a firm fixed price delivery order with an ultimate completion date of September 19, 2025, and represents a non-set-aside competitive award. The product will be delivered to the company's location in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and a primary distribution hub for federal pharmaceutical procurement. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen regularly fulfills diverse pharmaceutical requirements for military and veteran healthcare systems through this comprehensive IDC arrangement, which enables the company to supply brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Department of Defense medical operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 9/18/25 |